[Clinical considerations on the use of a new synthetic androgen, Calusterone, in the treatment of advanced breast cancer].

Abstract

Results with a new synthetic androgen (Calusterone) in the management of 22 cases of advanced breast cancer are presented. Reference is made to the doses employed, the therapeutic results observed, and the side-effects caused by the drug. By comparison with the literature data, a partial response to treatment was observed in 47% of the series.

• Authors: A de Matteis, V Perrone, A Marone
• Journal: Minerva medica (Minerva Med) Vol. 68 Issue 36 Pg. 2499-504 (Jul 28 1977) ISSN: 0026-4806 [Print] Italy
• Vernacular Title: Considerazioni cliniche sull'impiego di un nuovo androgeno di sintesi, il Calusterone, nella terapia del cancro della mammella in fase avanzata.
• PMID: 142218 (Publication Type: English Abstract, Journal Article)

Chemical References

• Methyltestosterone

Topics

• Adult
• Aged
• Breast Neoplasms (drug therapy)
• Drug Evaluation
• Female
• Humans
• Methyltestosterone (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
• Middle Aged
• Neoplasm Metastasis